South African virus variant may resist antibody drugs; Pfizer/BioNTech vaccine seems to work vs UK variant


FILE PHOTO: A vial and sryinge are seen in front of a displayed Pfizer and Biontech logo in this illustration taken January 11, 2021. REUTERS/Dado Ruvic

(Reuters) - The following is a roundup of some of the latest scientific studies on the novel coronavirus and efforts to find treatments and vaccines for COVID-19, the illness caused by the virus.

South African variant may resist current antibody treatments

The Star 6.6 DEAL: 35% OFF Digital Access

Monthly Plan

RM 13.90/month

RM 9.04/month

Billed as RM 9.04 for the 1st month, RM 13.90 thereafter.

Best Value

Annual Plan

RM 12.33/month

RM 8.02/month

Billed as RM 96.20 for the 1st year, RM 148 thereafter.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!

Next In World

North Korea says 'denuclearisation' is a matter terminated irreversibly
Mexico investigates murder of mayor of town in Oaxaca state
World Bank raises Uzbekistan's 2026 GDP growth forecast to 6.4 pct
Roundup: Thousands join Belfast anti-racism rally following days of unrest
UK's Starmer, Trump discuss efforts to end Iran conflict
Trump says Iran deal to be signed on Sunday
Flash: Trump says Iran deal to be signed Sunday
Trump to participate in G7 working session with Zelensky
What World Cup? New York gripped by Knicks frenzy
Trump to meet with Middle East leaders, attend Ukraine session at G7, US officials say

Others Also Read